Characterization of a novel human catechol-O-methyl-transferase mutant with triplet point mutations

International Journal of Molecular Medicine

Volumn 22, Issue 6, 2008, Pages 769-779

  Bai, Hyoung Woo ^a   Wang, Pan ^a   Zhu, Bao Ting ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Catechol O methyltransferase; Catechols

Indexed keywords

2 HYDROXYESTRADIOL; 4 HYDROXYESTRADIOL; CATECHOL METHYLTRANSFERASE; S ADENOSYLMETHIONINE;

ARTICLE; BINDING AFFINITY; CATALYSIS; CONTROLLED STUDY; ENZYME BINDING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; METHYLATION; MOLECULAR MODEL; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; THERMOSTABILITY;

CATECHOL O-METHYLTRANSFERASE; ESTRADIOL; ESTROGENS, CATECHOL; HAPLOTYPES; HUMANS; KINETICS; MODELS, MOLECULAR; POINT MUTATION; POLYMORPHISM, GENETIC; PROTEIN STABILITY; SEQUENCE ALIGNMENT;

EID: 65449135595     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000084     Document Type: Article

References (41)

1. Axelrod J and Tomchick R: Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233: 702-705, 1958.
2. Axelrod J: Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacol Rev 18: 95-113, 1996.
3. Zhu BT: Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab 3: 321-49, 2002.
4. Tenhunen J, Salminen M, Jalanko A, Ukkonen S and Ulmanen I: Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme. DNA Cell Biol 12: 253-263, 1993.
5. Zhu BT and Liehr JG: Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol Appl Pharmacol 125: 149-158, 1994.
6. Zhu BT, Patel UK, Cai MX and Conney AH: O-methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase. Drug Metab Dispos 28: 1024-1030, 2000.
7. Zhu BT, Ezell EL and Liehr JG: Catechol-O-methyltransferase-catalyzed rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo. J Biol Chem 269: 292-299, 1994.
8. Zhu BT and Liehr JG: Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis. J Biol Chem 271: 1357-1363, 1996.
9. Zhu BT: CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease. Int J Mol Med 13: 343-353, 2004.
10. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W and Diatchenko L: Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314: 1930-1933, 2006.
11. Diatchenoko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I Goldman D, Xu K, Shabalina SA, Shagin D, Max MB, Makarov SS and Maixner W: Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14: 135-143, 2005.
12. Shield AJ, Thomae BA, Eckloff BW, Wieben ED and Weinshilboum RM: Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol Psychiatry 9: 151-160, 2004.
13. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J and Gogos JA: Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94: 4572-4575, 1997.
14. Kirov G, Murphy KC, Arranz MJ, Jones I, McCandles F, Kunugi H, Murray RM, McGuffin P, Collier DA, Owen MJ and Craddock N: Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol Psychiatry 3: 342-345, 1998.
15. Papolos DF, Veit S, Faedda GL, Saito T and Lachman HM: Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry 3: 346-349, 1998.
16. Strous RD, Bark N, Parsia SS, Volavka J and Lachman HM: Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res 69: 71-77, 1997.
17. Tiihonen J, Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J, Syvälahti E, Hietala J and Tiihonen J: Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry 4: 286-289, 1999.
18. Enoch MA, Xu K, Ferro E, Harris CR and Goldman D: Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 13: 33-41, 2003.
19. Rosa A, Peralta V, Cuesta MJ, Zarzuela A, Serrano F, Martinez-Larrea A and Fañanás L: New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 161: 1110-1112, 2004.
20. Nolan KA, Bilder RM, Lachman HM and Volavka J: Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiatry 161: 359-361, 2004.
21. Illi A, Mattila KM, Kampman O, Anttila S, Roivas M and Lehtimaki T: Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia. J Clin Psychopharmacol 23: 429-434, 2003.
22. Zhu BT and Conney AH: Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19: 1-27, 1998.
23. Lee AJ, Cai MX, Tomas PE, Conney AH and Zhu BT: Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 144: 3382-3398, 2003.
24. Zhu BT and Conney AH: Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res 58: 2269-2277, 1998.
25. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM and Shen CY: Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility. Cancer Res 59: 4870-4875, 1999.
26. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M and Hirvonen A: Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev 10: 635-640, 2001.
27. Mitrunen K, Kataja V, Eskelinen M, Kosma VM, Kang D, Benhamou S, Vainio H, Uusitupa M and Hirvonen A: Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk. Pharmacogenetics 12: 67-72, 2002.
28. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF and Ambrosone CB: Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 58: 2107-2110, 1998.
29. Suzuki K, Nakazato H, Matsui H, Koike H, Okugi H, Kashiwagi B, Nishii M, Ohtake N, Nakata S, Ito K and Yamanaka H: Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population. Cancer 98: 1411-1416, 2003.
30. Yim DS, Parkb SK, Yoo KY, Yoon KS, Chung HH, Kang HL, Ahn SH, Noh DY, Choe KJ, Jang IJ, Shin SG, Strickland PT, Hirvonen A and Kang D: Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 11: 279-286, 2001.
31. Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, Guo C and Le Marchand L: Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev 10: 209-216, 2001.
32. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW and Yager JD: An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 57: 5493-5497, 1997.
33. Lee SG, Joo Y, Kim B, Chung S, Kim HL, Lee I, Choi B, Kim C and Song K: Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Hum Genet 116: 319-328, 2005.
34. Lotta T, Vidgren J, Tilgman C, Ulmanen I, Melen K, Julkunen I and Taskinen J: Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the therolabile variant of the enzyme. Biochemistry 34: 4202-4210, 1995.
35. Li Y, Yao J, Chang M, Nikolic D, Yu L and Yager JD: Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol O-methyltransferase. Chem Res Toxicol 17: 512-520, 2004.
36. Goodman JE, Jensen LT, He P and Yager JD: Characterization of human soluble high and low activity catechol O-methyltrasferase catalyzed catechol estrogen methylation. Pharmacogenetics 12: 517-528, 2002.
37. Li Y, Yang X, Breemen RB and Bolton JL: Characterization of two new variants of human catechol O-methyltransferase in vitro. Cancer Lett 230: 81-89, 2005.
38. Zhu BT, Roy D and Liehr JG: The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites. Endocrinology 132: 577-583, 1993.
39. Cohn CC, Dunner DL and Axelrod J: Reduced catechol-O-methyltransfease activity in red blood cells of women with primary affective disorder. Science 170: 125-135, 1970.
40. Tenhunen J and Ulmanen I: Production of rat soluble and membrane-bound catechol O-methyltransferase forms from bifunctional mRNAs. Biochem J 296(Pt 3): 595-600, 1993.
41. Winqvist R, Lundstrom K, Salminen M, Laatikainen M and Ulmanen I: The human catechol-O-methyltransferase (COMT) gene maps to band q11.2 of chromosome 22 and shows a frequent RFLP with BglI. Cytogenet Cell Genet 59: 253-257, 1992.